Date of Document: March 29, 2024
CURRICULUM VITAE

Syed Rizvi MD
Adjunct Assistant Professor
Department of Medicine
Division of Gastroenterology

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
1994 - 1999 M.B.B.S., Karachi Medical and Dental College, Karachi University, Pakistan

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
2002 - 2003 Internship, Internal Medicine, St. Barnabas Hospital, Well Medical College of Cornell University, NY
2003 - 2005 Residency, Internal Medicine, St. Barnabas Hospital, Weill Medical College of Cornell University, NY
2008 - 2009 Fellowship, Hepatology, Medical College of Wisconsin, Milwaukee, WI
2013 - 2015 Fellowship, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

FACULTY APPOINTMENTS:
2005 - 2008 Clinical Instructor, College of Human Medicine, Michigan State University, MI
2005 - 2008 Faculty Member, Family Medicine Residency, Marquette General Hospital, MI
2009 - 2013 Assistant Professor of Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI
2015 - Present Assistant Professor of Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
2009 - 2012 Director Hepatology Clinic, VA Zablocki Medical Center, Milwaukee, WI
2015 - Present Associate Medical Director of Liver Transplant, Froedtert Hospital, Milwaukee, WI
2015 - Present Director Hepatology Services, GI and Hepatology Section, VA Zablocki Medical Center, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
2009 - 2012 Froedtert Memorial Lutheran Hospital, Milwaukee, WI
2009 - 2012 Clement J. Zablocki VA Medical Center, Milwaukee, WI
2015 - Present Clement J. Zablocki VA Medical Center, Milwaukee, WI
2015 - Present Froedtert Memorial Lutheran Hospital, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Internal Medicine
08/2005
12/2015
Gatroenterology and Hepatology
11/2015
11/2025
   
Licensure
Number Issue DateExpiration
Wisconsin
51749-20
06/10/2008
10/31/2019
Michigan
40301085042
06/10/2008
10/31/2019
    

AWARDS AND HONORS:
"Resident of the Year PGYIII" , St. Barnabas Hospital, New York
"Teacher Physician of the year 2016", Gastroenterology and Hepatology, Medical College of Wisconsin
Certificate of Distinction in Anatomy and Physiology, Karachi Medical and Dental College, Karachi University, Pakistan

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Association for the Study of Liver Disease (AASLD)
American Gastroenterological Association (AGA)

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
Director of Hepatology Services, VA Zablocki Medical Center, Milwaukee, WI
Associate Medical Director of Liver Transplant, Medical College of Wisconsin, Milwaukee WI

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Non-Peer Review
Title:
STELLAR 3 - A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
PI:
Syed Rizvi,MD
  
Prior
Non-Peer Review
Title:
Banking of Hepatology database
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
Utilization and Outcomes of Endoscopic Surveillance and Non-Selective Beta-blockers for Secondary Prevention of Variceal Re-bleeding among U.S. Veterans
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
Collection of Blood Specimens From HCV Antibody Positive Subjects- COL-HCV-200 ROCHE Molecular Systems, Inc.
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
Incidence of Hepatocellular Carcinoma in Patients with HCV Treated with Directly Acting Antivirals
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
A Multicenter Open-Label Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2, and Ribavirin) in Subjects with Genotype 1 Chronic Hepatitis C with Compensated Cirrhosis- VX11-222-106-Vertex
PI:
Syed Rizvi, MD
  
Title:
Global Investigation of therapeutic Decisions in hepatocellular carcinoma and Of its treatment with Sorafenib- NX0802-GIDEON
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
An Expanded Access Phase 2 Study of Sofosbuvir with Ribavirin and with or without Pegylated Interferon for 24 weeks in Subjects who have undergone Liver Transplantation and Who Have Aggressive, Recurrent Hepatitis C Infection-Gilead
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
PI:
Syed Rizvi, MD
  
Title:
A Phase 3b Study of 2 Treatment Durations of Telaprevir, Peg-IFN (Pegasys®), and Ribavirin (Copegus®) in Treatment-Naive and Prior Relapser Subjects with Genotype 1 Chronic Hepatitis C and IL28B CC Genotype- VX11-950-114-Vertex
Role:
Sub-Investigator
  
Title:
Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (ornithine phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy-STOP-HE Study-OCERA
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
Outcomes of treatment of chronic hepatitis C in the era of directly acting
Role:
Sub-Investigator, Syed Rizvi, MD
  
Title:
Excess Prevalence of RLS in Liver Transplant Recipients - A Tertiary Care Center Experience
PI:
Syed Rizvi, MD
  
Title:
Comparison of management of Hepatocellular carcinoma in VA and Non-VA Tertiary, Medical Center
PI:
Syed Rizvi, MD
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
The Role of the Primary Care Physician in Liver Disease, MCW Annual Liver Disease Update, Milwaukee, WI, 03/26/2010
Nutrition in Patients with Liver Disease., MCW Annual Liver Disease Update, Milwaukee, WI, 03/26/2010
Hepatitis B Virus, MCW Annual AASLD Meeting Review, Milwaukee, WI, 12/04/2010
Hepatitis, UW-Milwaukee College of Nursing FNP program, Milwaukee, WI, 04/06/2011
Autoimmune Hepatitis, MCW Annual Liver Disease Update, Milwaukee, WI, 04/08/2011
Gallbladder and Biliary Disease, MCW Annual Liver Disease Update, Milwaukee, WI, 04/08/2011
Moderator, MCW Annual "State of the Gut" An Update on Gastrointestinal Disorders, Milwaukee, WI, 10/07/2011
Miscellaneous/Biliary/HCC, MCW Annual AASLD Meeting Review, Milwaukee, WI, 12/03/2011
Alcoholic Liver Disease, MCW Annual Liver Disease Update, Milwaukee, WI, 03/30/2012
Liver Disease for the Primary Care Physician, MCW Annual Liver Disease Update, Milwaukee, WI, 03/30/2012
What Should the Primary Care Physican do in Patients with Liver Disease?, MCW Annual "State of the Gut" An Update on Gastrointestinal Disorders, Milwaukee, WI, 09/28/2012
GI Malignancy Screening/Quality Measure, MCW Annual Digestive Disease Week Meeting Review, Milwaukee, WI, 09/28/2013
GI Malignancy Management, MCW Annual Digestive Disease Week Meeting Review, Milwaukee, WI, 09/20/2014
Hepatocellular Carcinoma & Metabolic, MCW Annual AASLD Meeting Review, Milwaukee, WI, 01/24/2015
Alcoholic Liver Disease, MCW Annual Liver Disease Update, Milwaukee, WI, 04/17/2015
Non-Alcoholic Liver Disease in 2015, MCW Annual Liver Disease Update, Milwaukee, WI, 04/17/2015
Miscellaneous Liver Topics, MCW Annual AASLD Meeting Reveiw, Milwaukee, WI, 01/23/2016
Metabolic and Malignancy, MCW Annual AASLD Meeting Review, Milwaukee, WI, 01/23/2016
Hepatocellular Carcinoma, MCW Annual Liver Disease Update, Milwaukee, WI, 04/15/2016
Overview of Viral Hepatitis A-E, MCW Annual Liver Disease Update, Milwaukee, WI, 04/15/2016
Hepatic Encephalopathy, MCW Annual "State of the Gut" An Update on Gastrointestinal Disorders, Milwaukee, WI, 09/30/2016
Evaluation of Liver Function Tests, Grand Rounds, St Agnes Hospital, Fond du Lac, WI, 10/06/2016
Malignancy/Transplant, MCW Annual AASLD Meeting Review, 02/04/2017
Hepatitis C Debate; Who to Treat and Who Not To Treat, MCW Annual Liver Disease Update, Milwaukee, WI, 04/28/2017
Myths in Hepatology, MCW Annual Liver Disease Update, Milwaukee, WI, 04/28/2017
Acute Alcoholic Hepatitis Management, Medical Education Program, Community Memorial Hospital, Milwaukee WI, 10/20/2017
Miscellaneous Liver Topics, MCW Annual AASLD Meeting Review, Milwaukee, WI, 02/03/2018
Hepatic Malignancies, MCW Annual Liver Disease Update, Milwaukee, WI, 04/27/2018
Hepatic Encephalopathy, MCW Annual Liver Disease Update, Milwaukee, WI, 04/27/2018
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
2010 Case Discussion M3 Medical Students
2011 Case Discussion M3 Medical Students
2011 CER History & Physical - 2nd year Medical Students
2014 Bench to Bedside teaching, M2 Medical Students
2015 Bench to Bedside teaching, M2 Medical Students
2015 Bench to Bedside, History and Physical of GI System, M2 Medical Students
2015 - 2016 Preceptor outpatient Hepatology specialty clinic for M4 medical students
2016 Master Clinician Course, Advanced Physical exam skills, M4 medical students
2016 Bench to Bedside, History and Physical of GI system, M2 medical students
2017 Master Clinician Course, Advanced Physical exam skills, M4 medical students
 
Resident and Fellow Education
2016 - Present Hepatology Core Curriculum Director for Gastroenterology Fellowship
Weekly case conference, Internal Medicine Residents
Staffing weekly case conference in Gastroenterology and Hepatology
Clinic Preceptor for Fellows and Internal Medicine Residents rotating through Hepatology Clinic
Staffing journal clubs in Hepatology for Residents and GI Fellows
 

EXTRAMURAL TEACHING:
Medical Student Education
St. Agnes Hospital, Fond du Lac, WI, Grand Rounds Lecture
Waukesha County Technical College in Hepatology, Invited Lecturer
University of Wisconsin Milwaukee, School of Nurse Practitioners, Invited Lecturer
 

PROGRAMMATIC DEVELOPMENTS:
 
 
Clinical Programs
Inpatient managment protocol development of Post-Liver Transplant immunosuppressive regimens
Inpatient management protocol development of patients with chronic Liver Disease
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Cahill JA; Rizvi S; Saeian K, Assessment of Adherence to Baselined Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center, American Journal of Medical Quality
 
Books, Chapters, and Reviews
1. Rizvi, S, Incidental hepatic lesions, In: Liver Disorders- A point of Care Clinical Guide, K Saeian & R Shaker eds. Springer, 43-49, 2017
2. Rizvi, S, Benign Liver lesions, In: Liver Disorders- A point of Care Clinical Guide, K Saeian & R Shaker eds. Springer, 51-69, 2017
3. Rizvi, S; Gawrieh, S, Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Springer, 589-602, 2018
 
Abstracts
1. M. Moizuddin: S.M.A. Rizvi; J.Berger. Clinical Vignette poster: Isolated pulmonic valve endocarditis caused by Streptococcus Viridians in Native Valve. New York ACP Chapter. November 15, 2004 Meeting
2. Patel A, Gawrieh S, Rizvi S, Xiang Q, Szabo A, Saeian K. Management Strategies Used for Nonalcoholic Fatty Liver Disease: Survey of AASLD Members. May 2009 Gastroenterology, Vol. 136, Issue 5, A-847.
3. R Franco, V Hotanalli, J Franco, S Rizvi, L Graf. Restless Legs Syndrome Symptoms in Patients with Liver Transplant and Quality of Life Preliminary Results. APPS International Meeting 2009. Seattle, WA. Sleep 32, A326.
4. A Patel, J Mankad, S Rizvi, J Franco, S Gawrieh, J Huang, K Saeian. The Role of Small Intestinal Bacterial Overgrowth in Minimal Hepatic Encephalopathy. 2012 AASLD Annual Liver Meeting, Boston, Massacheussets, November 2012.
5. B Schneeberger, J Mankad, A Libot, T Fang, K Saeian, S Rizvi. Comparison of HCC Stage at Diagnosis and Outcomes between a VA Medical Center and a Non-VA Tertiary Medical Center. Digestive Disease Week May 2012 Gastroenterology, Vol. 142, Issue 5, S-982–S-983
6. Martin E, Fang TC, Christensen K, Granlund K, Graf L, Grischeau M, Christianson J, Harrold SM. The Hematologic Effects of Pegylated Interferon, Ribavirin, and Boceprevir or Telaprevir: A Single Center Experience. May 2013 Gastroenterology, Vol. 144, Issue 5, S-985–S-986
7. Cahill J, Rizvi S, Saeian K. Assessment of Adherence to Baseline Quality Measures for Cirrhosis and Impact of ‘Performance Feedback’ in a Regional VA Medical Center. April 2015 Gastroenterology, Vol. 148, Issue 4, S-1071
8. Stein D, Rizvi S, Modiri AN, Fang T, Naik AS. Two Case Reports of Toxic Megacolon From Clostridium difficile Infection Successfully Treated With Fecal Microbiota Therapy. April 2015 Gastroenterology, Vol. 148, Issue 4, S-645
9. Modiri AN, Naik AS, Rizvi S, Zadvornova Y, Stein D. Inflammatory Bowel Disease Patients With Solid Organ Transplants Who Require Anti-TNF Therapy Are Not at Increased Risk of Serious Infections. April 2015 Gastroenterology, Vol. 148, Issue 4, S-61
10. Kern T, Wichmann A, Arnhoelter K, Ruoff K, Bode J, Wolfmeyer R, Rizvi S, A Novel Process for Hepatitis C Virus Screening in the Veteran Baby Boomer Population. American Journal of Gastroenterology, Vol 112, Issue1, S-521
11. Esteban PG, Saeian K, Rizvi S, Increasing incidence of MELD exception applications for hepatocellular cancer among hepatitis C patients waiting for transplant in the era of direct acting antivirals. October 2017, Hepatology, Vol. 66, Issue 1, S-556A
12. Esteban PG, Rizvi S, Saeian K, Low serum concentration of carotenoids is associated with non-alcoholic fatty liver disease (NAFLD). October 2017, Hepatology, Vol. 66, Issue 1, S- 1150A
13. Daniel K, Rizvi S, Seaian K, Real-World Experiences with Direct-Acting Antivirals for Hepatitis C Treatment. October 2017, Hepatology, Vol. 66, Issue 1, S- 840A